ผลกระทบของการเกิดอนุมูลอิสระจากโรคเบาหวานต่อการทำงานของไต
Article Sidebar
Main Article Content
Abstract
...
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ส่งมาลงพิมพ์ต้องไม่เคยพิมพ์หรือกำลังได้รับการพิจารณาตีพิมพ์ในวารสารอื่น เนื้อหาในบทความต้องเป็นผลงานของผู้นิพนธ์เอง ไม่ได้ลอกเลียนหรือตัดทอนจากบทความอื่น โดยไม่ได้รับอนุญาตหรือไม่ได้อ้างอิงอย่างเหมาะสม การแก้ไขหรือให้ข้อมูลเพิ่มเติมแก่กองบรรณาธิการ จะต้องเสร็จสิ้นเป็นที่เรียบร้อยก่อนจะได้รับพิจารณาตีพิมพ์ และบทความที่ตีพิมพ์แล้วเป็นสมบัติ ของลำปางเวชสาร
References
American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001; 24(1):S5-10.
American Diabetes Association. Medical management of type 2 diabetes. 4th ed. Alexandria: American Diabetes Association; 1998. p.56-72.
Cnop M, Welsh N, J¨orns JC, Lenzen S, Decio LE. Mechanisms of pancreatic a-cell death in type 1 and type 2 diabetes. Diabetes 2005;54(Suppl 2):S97–107.
Zhao YF, Feng DD, Chen C. Contribution of adipocytederived factors to beta-cell dysfunction in diabetes.
Int J Biochem Cell Biol 2006;38:804–19.
U.S. Renal Data System, USRDS 2000 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2000.
Silbernagl S. Color atas of pysiology. 5th ed. Wemding: GmbH&Co; 2003. 7. Thomas MC, Jerums G, Tsalamadris C et al. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Kidney Int 2005; 67:2494–9.
Pritchard JB. Coupled transport of p-aminohippurate by rat kidney basolateral membrane vesicles. Am J Physiol 1988;255:F597-604.
Bae SK, Kang HE, Kang MK, Kim JW, Kim T, Lee MG. Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats. J Pharm Sci 2006;95(5):998–1005.
Kim YC, Lee AK, Lee JH, Lee I, Lee DC, Kim SH, Kim SG, Lee MG. Pharmacokinetics of theophylline 1,3-dimethyluric acid formation. Eur J Pharm Sci 2005;26(1):114–23.
Kim YC, Oh EY, Kim SH, Lee MG. Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin. Biopharm Drug Dispos 2005;26 (8):371–8.
Kim YC, Lee JH, Kim SH, Lee MG. Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus. Antimicrob Agents Chemother 2005;49(6):2528–32.
Park JH,Lee WI,Yoon WH,Park YD, Lee JS, Lee MG. Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus. Biopharm Drug Dispos 1998;19(6):357–64.
Park JM, Moon CH, Lee MG. Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin induced diabetes mellitus rats. Res Commun Mol Pathol Pharmacol 1996;93(3):343–352.
Watkins JB III, Sherman SE. Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. J Pharmacol Exp Ther 1992;260(3):1337–43.
Thomas MC, Tikellis C, Burns WC, Thallas V, Forbes JM, Cao Z, et al. Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney Int 2003;63:2152–61.
Grover B, Buckley D, Buckley AR, Cacini W. Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes. J Phramacol Exp Ther 2004;308:949-56.
Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science1996; 3;272(5262):728-31.
Han H, Lee YJ, Park SH, Lee JH, Taub M. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 2005;288:F988-96.
Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int 2000;77:S3-12.
Lelkes E, Unsworth BR, Lelkes PI. Reactive oxygen species, apoptosis and altered NGFinduced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic nephropathy. Neurotox Res 2001;3: 189-203.
Handschin C, Meyer UA. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 2005;433: 387-94.
Jahn R, Lang T, Südhof TC. Membrane fusion. Cell 2003;112: 519-53.
Tobi D, Wiser O, Trus M, Atlas,D. N-type voltage-sensitive calcium channel interacts with syntaxin, synaptotagmin and SNAP-25 in a multiprotein complex. Receptors Channels 1998;6:89-98.
Mistry AC, Mallick R, Fröhlich O, Klein JD, Rehm R, Chen G, et al. The UT-A1 urea transport er interacts with snapin, a SNARE-associated protein. J Biol Chem 2007;282(41):30097-106.
Giniatullin AR, Darios F, Shakirzyanova A, Davletov B, Giniatullin R. SNAP25 is a presynaptic target for the depressant action of reactive oxygen species on transmitter release. J Neurochem 2006;98:1789-97.
Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000;80:717–66.
Sudhof TC. Synaptic vesicle cycle. Ann Rev Neurosci 2004;27:509-47.